Key points are not available for this paper at this time.
Objectives Strong evidence suggests the occurrence of cerebral microbleeds (CMBs) in 5–13% of stroke patients within the first week after stroke onset. The aim of this work was to study risk factors associated with occurrence of CMBs in patients with stroke who received intravenous thrombolysis, and to clarify their impact on the clinical outcome.
Oraby et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: